Galera Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on advancing a pan-NOS inhibitor through clinical development for patients with the hardest-to-treat forms of advanced breast cancer.
Back to dashboard
Company Information
About this company
Key people
J. Mel Sorensen
Chairman of the Board, President, Chief Executive Officer
Joel F. Sussman
Chief Accounting Officer, Secretary and Treasurer
Michael Friedman
Director
Lawrence M. Alleva
Independent Director
Nancy T. Chang
Independent Director
Kevin Lokay
Independent Director
Click to see more
Key facts
- Shares in issue1.04m
- EPICGRTXD
- ISINUS36338D2071
- LocationUnited States
- SectorHealthcare
- IndustryBiotechnology & Drugs
- Market cap$18.18m
- Employees3
- ExchangeOver The Counter
- Index
- Website
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.